Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.12
|
1.17
|
1.17
|
1.17
|
1.18
|
1.17
|
|
|
4 975.41
|
35.00
|
1.12
|
1.24
|
1.13
|
1.13
|
1.17
|
1.17
|
|
|
6 999.76
|
57.00
|
1.11
|
1.15
|
1.11
|
1.11
|
1.14
|
1.13
|
|
|
16 291.58
|
82.00
|
1.04
|
1.11
|
1.09
|
1.09
|
1.11
|
1.11
|
|
|
11 285.33
|
32.00
|
1.05
|
1.12
|
1.11
|
1.10
|
1.12
|
1.10
|
|
|
6 404.57
|
39.00
|
1.05
|
1.15
|
1.08
|
1.06
|
1.09
|
1.08
|
|
|
20 246.81
|
43.00
|
1.04
|
1.10
|
1.05
|
1.04
|
1.12
|
1.09
|
|
|
4 081.52
|
35.00
|
1.03
|
1.15
|
1.05
|
1.04
|
1.06
|
1.06
|
|
|
1 726.63
|
14.00
|
1.02
|
1.12
|
1.06
|
1.04
|
1.06
|
1.04
|
|
|
5 054.99
|
29.00
|
1.04
|
1.09
|
1.05
|
1.04
|
1.07
|
1.04
|
|
|
6 714.40
|
33.00
|
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer.